Trial Profile
Influence of the PPAR gamma -agonist Pioglitazone on endothelial function in the peripheral and myocardial vascular territories and on myocardial efficiency in obese subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Insulin resistance
- Focus Pharmacodynamics
- 09 Nov 2016 New trial record